Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Work In Process (2016 - 2025)

Standard Biotools (LAB) has disclosed Work In Process for 15 consecutive years, with $253000.0 as the latest value for Q4 2025.

  • Quarterly Work In Process fell 42.89% to $253000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $253000.0 through Dec 2025, down 42.89% year-over-year, with the annual reading at $253000.0 for FY2025, 42.89% down from the prior year.
  • Work In Process for Q4 2025 was $253000.0 at Standard Biotools, down from $270000.0 in the prior quarter.
  • The five-year high for Work In Process was $28.9 million in Q1 2025, with the low at $253000.0 in Q4 2025.
  • Average Work In Process over 5 years is $2.1 million, with a median of $640000.0 recorded in 2024.
  • Peak annual rise in Work In Process hit 4310.38% in 2025, while the deepest fall reached 82.67% in 2025.
  • Over 5 years, Work In Process stood at $867000.0 in 2021, then grew by 9.0% to $945000.0 in 2022, then plummeted by 53.12% to $443000.0 in 2023, then changed by 0.0% to $443000.0 in 2024, then crashed by 42.89% to $253000.0 in 2025.
  • According to Business Quant data, Work In Process over the past three periods came in at $253000.0, $270000.0, and $414000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.